OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.4 BRL | +0.19% |
|
-1.38% | -17.72% |
Strengths
- With a P/E ratio at 11.46 for the current year and 10.31 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -17.72% | 227M | - | ||
| -3.79% | 88.14B | A- | ||
| +1.45% | 40.51B | A- | ||
| -15.94% | 31.67B | B- | ||
| +52.66% | 24.62B | A | ||
| -14.50% | 15.65B | C | ||
| -14.38% | 12.07B | B- | ||
| -9.12% | 11.97B | D+ | ||
| -42.56% | 11.61B | B | ||
| +4.87% | 8.81B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- OFSA3 Stock
- Ratings Ouro Fino Saúde Animal Participações S.A.
